K-C Worldwide issued US patent for 'absorbent article having line of weakness for folding the article'

Nevin Barich

ALEXANDRIA, Virginia , May 6, 2014 (U.S. Fed News) – United States Patent no. 8,715,261, issued on May 6, was assigned to Kimberly-Clark Worldwide Inc. (Neenah, Wis.).

"Absorbent article having line of weakness for folding the article" was invented by Carmen Lira (Appleton, Wis.) and Adrienne Rae Loyd (Neenah, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A feminine care absorbent article has a longitudinal axis, a transverse axis, and an absorbent structure configured for disposition adjacent a female wearer's vaginal region to absorb bodily fluids discharged by the wearer. The absorbent structure has end portions and a middle portion located between the end portions. The absorbent structure has at least one line of weakness disposed in one of the end portions and configured to facilitate folding of the absorbent structure in a longitudinal direction in response to a lateral compressive force. The absorbent structure has a relief for inhibiting the longitudinal folding of the absorbent structure facilitated by the at least one line of weakness from extending beyond the middle portion of the absorbent structure."

The patent was filed on March 19, 2012, under Application No. 13/423,400.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8715261&OS=8715261&RS=8715261

For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com

(c) 2014 US Fed News (HT Syndication)

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.